Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-4547|93|12|1849-1864

ISSN： 0360-4012

Source： JOURNAL OF NEUROSCIENCE RESEARCH, Vol.93, Iss.12, 2015-12, pp. : 1849-1864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sparing of orexin‐A and orexin‐B neurons in the hypothalamus and of orexin fibers in the substantia nigra of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated macaques

By  

EUROPEAN JOURNAL OF NEUROSCIENCE, Vol. 41, Iss. 1, 2015-01 ,pp. : 129-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Melatonin enhances L‐DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonism in mice

By  

JOURNAL OF PINEAL RESEARCH (ELECTRONIC), Vol. 58, Iss. 3, 2015-04 ,pp. : 262-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 360-4012, Iss. 11, 2015-11 ,pp. : 1713-1727

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apoptotic Mediators are Upregulated in the Skeletal Muscle of Chronic/Progressive Mouse Model of Parkinson's Disease

By  

THE ANATOMICAL RECORD : ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, Vol. 298, Iss. 8, 2015-08 ,pp. : 1472-1478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serotonergic dysfunction in the A53T alpha‐synuclein mouse model of Parkinson's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 135, Iss. 3, 2015-11 ,pp. : 589-597

John Wiley & Sons Inc

Access to resources Recommend Favorite